The global dementia drugs market has been steadily expanding, reaching a valuation of USD 16.6 billion in 2024 across the 7 major markets. This growth is primarily driven by the increasing prevalence of dementia, including Alzheimer’s disease, as populations age worldwide. With no definitive c